Global Biosimilar Monoclonal Antibodies Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 138025
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 128
  • list Pharmaceuticals and Healthcare

A monoclonal antibody is a type of protein made in the laboratory that can bind to substances in the body, including cancer cells. A monoclonal antibody is made so that it binds to only one substance to treat different types of cancer. There are several types of monoclonal antibodies that are being used to treat certain types of cancer. Laboratory production of monoclonal antibodies is produced from clones of only one cell which means that every monoclonal antibody produced by the cell is the same due to which they are called as biosimilar monoclonal antibodies. Each monoclonal antibody recognizes one particular protein. They work in different ways depending on the protein they are targeting, hence different monoclonal antibodies are required to be made to target different types of cancer.

Scope of the Report:

This report focuses on the Biosimilar Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Biosimilar Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

Pfizer, Inc.

Novartis AG

Reliance Life Sciences

Allergan plc

Coherus BioSciences, Inc.

Biocon

Dr. Reddy's Laboratories Ltd.

Boehringer Ingelheim GmbH

BioXpress Therapeutics SA

Intas Pharmaceuticals Limited

BIOCAD

Genor BioPharma Co. Ltd

Celltrion, Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Rituximab

Infliximab

Abciximab

Trastuzumab

Adalimumab

Bevacizumab

Market Segment by Applications, can be divided into

Oncology

Chronic and Autoimmune Diseases

Growth Hormone Deficiency

Infectious Diseases

Others

There are 15 Chapters to deeply display the global Biosimilar Monoclonal Antibodies market.

Chapter 1, to describe Biosimilar Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Biosimilar Monoclonal Antibodies, with sales, revenue, and price of Biosimilar Monoclonal Antibodies, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Biosimilar Monoclonal Antibodies, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Biosimilar Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Biosimilar Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Biosimilar Monoclonal Antibodies Introduction

1.2 Market Analysis by Type

1.2.1 Rituximab

1.2.2 Infliximab

1.2.3 Abciximab

1.2.4 Trastuzumab

1.2.5 Adalimumab

1.2.6 Bevacizumab

1.3 Market Analysis by Applications

1.3.1 Oncology

1.3.2 Chronic and Autoimmune Diseases

1.3.3 Growth Hormone Deficiency

1.3.4 Infectious Diseases

1.3.5 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Pfizer, Inc.

2.1.1 Business Overview

2.1.2 Biosimilar Monoclonal Antibodies Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Pfizer, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Novartis AG

2.2.1 Business Overview

2.2.2 Biosimilar Monoclonal Antibodies Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Novartis AG Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Reliance Life Sciences

2.3.1 Business Overview

2.3.2 Biosimilar Monoclonal Antibodies Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Reliance Life Sciences Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Allergan plc

2.4.1 Business Overview

2.4.2 Biosimilar Monoclonal Antibodies Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Allergan plc Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Coherus BioSciences, Inc.

2.5.1 Business Overview

2.5.2 Biosimilar Monoclonal Antibodies Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Coherus BioSciences, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Biocon

2.6.1 Business Overview

2.6.2 Biosimilar Monoclonal Antibodies Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Biocon Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Dr. Reddy's Laboratories Ltd.

2.7.1 Business Overview

2.7.2 Biosimilar Monoclonal Antibodies Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Dr. Reddy's Laboratories Ltd. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Boehringer Ingelheim GmbH

2.8.1 Business Overview

2.8.2 Biosimilar Monoclonal Antibodies Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Boehringer Ingelheim GmbH Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 BioXpress Therapeutics SA

2.9.1 Business Overview

2.9.2 Biosimilar Monoclonal Antibodies Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 BioXpress Therapeutics SA Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Intas Pharmaceuticals Limited

2.10.1 Business Overview

2.10.2 Biosimilar Monoclonal Antibodies Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Intas Pharmaceuticals Limited Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 BIOCAD

2.11.1 Business Overview

2.11.2 Biosimilar Monoclonal Antibodies Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 BIOCAD Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Genor BioPharma Co. Ltd

2.12.1 Business Overview

2.12.2 Biosimilar Monoclonal Antibodies Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Genor BioPharma Co. Ltd Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Celltrion, Inc.

2.13.1 Business Overview

2.13.2 Biosimilar Monoclonal Antibodies Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Celltrion, Inc. Biosimilar Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biosimilar Monoclonal Antibodies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017

3.3.2 Top 6 Biosimilar Monoclonal Antibodies Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Biosimilar Monoclonal Antibodies Market Analysis by Regions

4.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Regions

4.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Regions (2013-2018)

4.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Regions (2013-2018)

4.2 North America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

4.3 Europe Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

4.5 South America Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

5 North America Biosimilar Monoclonal Antibodies by Countries

5.1 North America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries

5.1.1 North America Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)

5.1.2 North America Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)

5.2 United States Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

5.3 Canada Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

5.4 Mexico Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6 Europe Biosimilar Monoclonal Antibodies by Countries

6.1 Europe Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries

6.1.1 Europe Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)

6.2 Germany Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6.3 UK Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6.4 France Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6.5 Russia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

6.6 Italy Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

7 Asia-Pacific Biosimilar Monoclonal Antibodies by Countries

7.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)

7.2 China Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

7.3 Japan Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

7.4 Korea Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

7.5 India Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

8 South America Biosimilar Monoclonal Antibodies by Countries

8.1 South America Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries

8.1.1 South America Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)

8.1.2 South America Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

8.3 Argentina Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

8.4 Colombia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

9 Middle East and Africa Biosimilar Monoclonal Antibodies by Countries

9.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

9.3 UAE Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

9.4 Egypt Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

9.5 Nigeria Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

9.6 South Africa Biosimilar Monoclonal Antibodies Sales and Growth Rate (2013-2018)

10 Global Biosimilar Monoclonal Antibodies Market Segment by Type

10.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Biosimilar Monoclonal Antibodies Sales and Market Share by Type (2013-2018)

10.1.2 Global Biosimilar Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)

10.2 Rituximab Sales Growth and Price

10.2.1 Global Rituximab Sales Growth (2013-2018)

10.2.2 Global Rituximab Price (2013-2018)

10.3 Infliximab Sales Growth and Price

10.3.1 Global Infliximab Sales Growth (2013-2018)

10.3.2 Global Infliximab Price (2013-2018)

10.4 Abciximab Sales Growth and Price

10.4.1 Global Abciximab Sales Growth (2013-2018)

10.4.2 Global Abciximab Price (2013-2018)

10.5 Trastuzumab Sales Growth and Price

10.5.1 Global Trastuzumab Sales Growth (2013-2018)

10.5.2 Global Trastuzumab Price (2013-2018)

10.6 Adalimumab Sales Growth and Price

10.6.1 Global Adalimumab Sales Growth (2013-2018)

10.6.2 Global Adalimumab Price (2013-2018)

10.7 Bevacizumab Sales Growth and Price

10.7.1 Global Bevacizumab Sales Growth (2013-2018)

10.7.2 Global Bevacizumab Price (2013-2018)

11 Global Biosimilar Monoclonal Antibodies Market Segment by Application

11.1 Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2013-2018)

11.2 Oncology Sales Growth (2013-2018)

11.3 Chronic and Autoimmune Diseases Sales Growth (2013-2018)

11.4 Growth Hormone Deficiency Sales Growth (2013-2018)

11.5 Infectious Diseases Sales Growth (2013-2018)

11.6 Others Sales Growth (2013-2018)

12 Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.1 Global Biosimilar Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)

12.2 Biosimilar Monoclonal Antibodies Market Forecast by Regions (2018-2023)

12.2.1 North America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.2.2 Europe Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.2.3 Asia-Pacific Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.2.4 South America Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.2.5 Middle East and Africa Biosimilar Monoclonal Antibodies Market Forecast (2018-2023)

12.3 Biosimilar Monoclonal Antibodies Market Forecast by Type (2018-2023)

12.3.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2018-2023)

12.3.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Type (2018-2023)

12.4 Biosimilar Monoclonal Antibodies Market Forecast by Application (2018-2023)

12.4.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2018-2023)

12.4.2 Global Biosimilar Monoclonal Antibodies Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Biosimilar Monoclonal Antibodies Picture

Table Product Specifications of Biosimilar Monoclonal Antibodies

Figure Global Sales Market Share of Biosimilar Monoclonal A

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery